Coupe N, Schadendorf D, Danson S, et al. PACMEL: A randomised phase 2 study of paclitaxel with or without trametinib or pazopanib in Advanced BRAF wild type melanoma. SMR 2017, abstract SMR05-2.
Cemiplimab bij gemetastaseerd basaalcelcarcinoom na hedgehog pathway inhibitors
apr 2024 | Dermato-oncologie, Immuuntherapie